We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

205 hedge funds and large institutions have $3.58B invested in Pacira BioSciences in 2015 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 36

3% more funds holding

Funds holding: 200 → 205 (+5)

6% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 71

3% more capital invested

Capital invested by funds: $3.48B → $3.58B (+$102M)

0% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $27.4M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
205
Holders Change
+5
Holders Change %
+2.5%
% of All Funds
5.46%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
41
Increased
75
Reduced
71
Closed
36
Calls
$27.4M
Puts
$27.4M
Net Calls
+$19K
Net Calls Change
-$7.62M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$73.9M
2
JHIU
Janus Henderson Investors US
Colorado
+$57.4M
3
MCM
Marsico Capital Management
Colorado
+$27.4M
4
SI
Standard Investments
New York
+$27.1M
5
PC
PointState Capital
New York
+$23.3M

Top Sellers

Rank Fund Capital Flow
1
NCGI
Next Century Growth Investors
Minnesota
-$30.8M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$21.8M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$18.5M
4
CCI
Columbus Circle Investors
-$16.7M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
EMG
101
Ellington Management Group
Connecticut
$2.05M +$1.62M +16,000 +225%
PPA
102
Parametric Portfolio Associates
Washington
$2.01M +$341K +3,363 +17%
VFA
103
Virtus Fund Advisers
Connecticut
$1.96M +$312K +3,072 +16%
NIP
104
Nicholas Investment Partners
California
$1.86M -$695K -6,847 -25%
WSA
105
Wall Street Associates
California
$1.78M -$1.2M -11,798 -37%
CPIM
106
Columbia Partners Investment Management
Virginia
$1.77M -$27.8K -274 -1%
SI
107
Stephens Inc
Arkansas
$1.77M +$59.5K +586 +3%
SAM
108
Security Asset Management
New York
$1.73M +$303K +2,988 +18%
Franklin Resources
109
Franklin Resources
California
$1.66M +$206K +2,030 +12%
AA
110
ALPS Advisors
Colorado
$1.6M +$1.83M +18,035 New
DekaBank Deutsche Girozentrale
111
DekaBank Deutsche Girozentrale
Germany
$1.51M -$230K -2,270 -12%
WA
112
Whitebox Advisors
Minnesota
$1.5M +$1.72M +16,930 New
Group One Trading
113
Group One Trading
Illinois
$1.39M +$1.59M +15,689 New
TAM
114
Tocqueville Asset Management
New York
$1.36M +$181K +1,780 +13%
BG
115
BlackRock Group
United Kingdom
$1.29M +$537K +5,297 +57%
WMSA
116
Weiss Multi-Strategy Advisers
New York
$1.24M -$203K -2,000 -13%
SAM
117
Sectoral Asset Management
Quebec, Canada
$1.24M +$1.41M +13,939 New
EAM
118
Eventide Asset Management
Massachusetts
$1.18M – – –
UBS Group
119
UBS Group
Switzerland
$1.17M -$606K -5,970 -31%
CC
120
Curian Capital
Colorado
$1.17M +$17.4K +171 +1%
VIA
121
Vident Investment Advisory
Georgia
$1.06M +$1.22M +11,985 New
AQR Capital Management
122
AQR Capital Management
Connecticut
$1.02M -$597K -5,886 -34%
TI
123
Trexquant Investment
Connecticut
$1M +$1.15M +11,300 New
WIC
124
Woodmont Investment Counsel
Tennessee
$954K +$477K +4,700 +78%
Stifel Financial
125
Stifel Financial
Missouri
$942K +$104K +1,022 +11%
3 4
5
6 7

PCRX Hedge Fund Activity: Q1 2015 in Review

205 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q1 2015, worth a combined $3.58B — up 2.9% from $3.48B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new PCRX positions and 36 closed out — a net gain of 5 holders — while 75 added to existing stakes and 71 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $73.9M. The largest seller was Next Century Growth Investors, cutting an estimated $30.8M.

  • 205 institutional investors held Pacira BioSciences (PCRX) as of Q1 2015, up from 200 in Q4 2014.
  • Funds reported $3.58B of Pacira BioSciences stock for Q1 2015, up 2.9% quarter-over-quarter.
  • 41 funds opened new Pacira BioSciences positions in Q1 2015 and 36 closed out, a net change of +5 holders.
  • The largest Pacira BioSciences buyer in Q1 2015 was Westfield Capital Management, an estimated $73.9M added.
  • The largest Pacira BioSciences seller in Q1 2015 was Next Century Growth Investors, an estimated $30.8M sold.

Based on aggregated 13F filings for Q1 2015.